REG - FIL Limited Covidien plc Medtronic, Inc. - Form 8.3 - MEDTRONIC INC <Origin Href="QuoteRef">COV.N</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
RNS Number : 9462RFIL Limited17 September 2014FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2007 (AS AMENDED)DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE1. KEY INFORMATION
Name of person dealing (Note 1)
FMR LLC and/or one or more of its direct or indirect subsidiaries
And
FIL Limited and/or one or more of its direct and indirect subsidiaries
Company dealt in
MEDTRONIC INC
Class of relevant security to which the dealings being disclosed relate(Note 2)
Ordinary shares
Date of dealing
16-September-14
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security
dealt in(Note 3)
Long
Short
Number (%)
Number (%)
(1) Relevant securities
20,600,608 2.10
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
4,000 0.00
Total
20,600,608 2.10
4,000 0.00
(b) Interests and short positions in relevant securities of the company, other than the
class dealt in(Note 3)
Class of relevant security:
Long
Short
Number (%)
Number (%)
(63) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
3. DEALINGS(Note 4)
Purchases and sales
Purchase/sale
Number of securities
Price per unit
Buy
300
65.1900 USD/ Share
Buy
1,115
65.1924 USD/ Share
Buy
534
66.1277 USD/ Share
Buy
2,036
66.1253 USD/ Share
Buy
573
66.1570 USD/ Share
Buy
500
66.1660 USD/ Share
Buy
400
66.1500 USD/ Share
Buy
1,900
65.9824 USD/ Share
Buy
2,200
66.1609 USD/ Share
Buy
3,250
66.1132 USD/ Share
Buy
3,900
66.1103 USD/ Share
Buy
5,200
66.1984 USD/ Share
Buy
5,800
65.2076 USD/ Share
Buy
6,900
65.2020 USD/ Share
Buy
8,600
66.1498 USD/ Share
Buy
9,900
65.2036 USD/ Share
Buy
11,600
65.1941 USD/ Share
Buy
13,000
65.9711 USD/ Share
Buy
36,079
66.1119 USD/ Share
Buy
44,766
66.1204 USD/ Share
Buy
72,520
66.0848 USD/ Share
Buy
94,000
65.2650 USD/ Share
Buy
26,379
64.6979 USD/ Share
Buy
395
64.8400 USD/ Share
Buy
3
64.9800 USD/ Share
Buy
220
64.9000 USD/ Share
Buy
9
64.8600 USD/ Share
Sale
10,000
64.7143 USD/ Share
Sale
800
65.2806 USD/ Share
Sale
3
66.1900 USD/ Share
Sale
18
64.9700 USD/ Share
Sale
15
64.8200 USD/ Share
Sale
13
64.8800 USD/ Share
Sale
2
64.8100 USD/ Share
Sale
2
64.8500 USD/ Share
Sale
62
64.8150 USD/ Share
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name,
e.g. call option
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise
price
Type, e.g. American, European etc.
Expiry
date
Option money
paid/received per unit (Note 5)
(ii) Exercising
Product name, e.g. call option
Number of securities
Exercise price per unit (Note 5)
(d) Other dealings (including transactions in respect of new securities)(Note 4)
Nature of transaction (Note 8)
Details
Price per unit (if applicable)(Note 5)
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
Is a Supplemental Form 8 attached?(Note 9)YES
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL
ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as
appropriate)
Product description e.g. call option
Written or purchased
Number of securities to which option or derivative relates
Exercise price per unit
Type
e.g. American, European etc.
Expiry date
Call Option
Written
500
USD 65.00
American
20 September 2014
Call Option
Written
500
USD 70.00
American
22 November 2014
Call Option
Written
1,000
USD 70.00
American
17 January 2015
Call Option
Written
1,000
USD 67.50
American
22 November 2014
Call Option
Written
1,000
USD 65.00
American
18 October 2014
Date of disclosure
17 September 2014
Contact name
Nevelina Rousseva-Gasnier
Telephone number
+44 (0)1737 837216
If a connected EFM, name of offeree/offeror with which connected
N/A
If a connected EFM, state nature of connection (Note 10)
N/A
This information is provided by RNSThe company news service from the London Stock ExchangeENDISEXDLFFZKFEBBD
Recent news on Medtronic
See all newsRCS - Cydar Ltd - First patient treated in Medtronic collaboration
AnnouncementRCS - Cydar Ltd - Kenneth Hitchner appointed Cydar Medical Chairman
AnnouncementRCS - Cydar Ltd - Cydar Medical raises $11.5m (£9.3m) in Series A
AnnouncementREG - Baillie GiffordJapan - Net Asset Value(s) <Origin Href="QuoteRef">BGFD.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
AnnouncementREG - Goldman Sachs (EPT) Greene King PLC - Form 8.5 (EPT/RI) - Amendment <Origin Href="QuoteRef">GNK.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
Announcement